$CLMT

Calumet stock hits 52-week high at 54.72 USD

Calumet Specialty Products Partners (CLMT) hit a 52-week high of $54.72, up 205.27% over the past year. The company reported Q2 2026 revenue of $1.44B, beating estimates, but missed earnings expectations. S&P upgraded its credit rating to 'B-', while UBS and TD Cowen raised price targets to $47 and $40, respectively, with Neutral/Hold ratings.

Original reporting
Published Sep 9, 2026, 1:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 6:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CLMT
Neutral
medium confidence
Mentioned
$CLMT
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CLMTNeutralMed
01

Why it matters

The earnings release and rating upgrades provide fresh data for traders to reassess CLMT's valuation.

02

Market read

Earnings miss with revenue beat and rating upgrades create a nuanced trading signal for CLMT and the broader specialty fuels sector.

03

What to watch

Planned downtime at Montana Renewables could suppress future production and earnings.

Relevance 7/10Novelty 6/10Timing: today

Background

Calumet Specialty Products Partners (CLMT) hit a 52‑week high amid strong price moves in energy markets, while its Q2 earnings were released.

Company-level read

Ticker impact

$CLMTNeutralMedium confidence
Context

Calumet Specialty Products Partners reported Q2 2026 revenue of $1.44B beating estimates but posted an adjusted loss of $1.09 per share, prompting S&P upgrade and new price targets.

Expected impact

Potential modest upside if price targets are re‑priced, but downside risk from loss per share.

Evidence & confidence

Mixed fundamentals (beat revenue, miss earnings) and analyst upgrades indicate a balanced market reaction.

Market effects

Specialty oils and renewable fuels sector may see increased attention as Calumet's credit upgrade highlights industry resilience.

U.S. energy stocks could experience modest ripple effects from the rating upgrade.

Limited to investors tracking mid‑cap energy companies.

Counterpoint

The earnings loss may signal deeper margin pressure despite revenue beat, suggesting caution.

Key entities

  • Calumet Specialty Products Partners

    U.S. specialty oil and renewable fuels producer.

  • S&P Global Ratings

    Upgraded CLMT's credit rating to B-.

  • UBS

    Raised price target to $47.

  • TD Cowen

    Raised price target to $40.

Related articles

$CLMTMed

Q2 Earnings Highlights: Calumet (NASDAQ:CLMT) Vs The Rest Of The Infrastructure Stocks

Calumet (CLMT) stock rose 8.9% post-earnings, trading at $16.19. Kodiak Gas Services (KGS) reported $391.1M revenue, up 21.1% YoY, with stock up 10.5% to $62.81. Excelerate Energy (EE) saw $329.3M revenue, up 61% YoY, with stock up 3% to $39.65. DHT Holdings (DHT) reported $255.2M revenue, up 174% YoY, with stock up 13% to $20.19. Market focus has shifted from AI to geopolitics and back to fundamentals.

$CLMTMed

Why Calumet Stock Topped the Market Today

Calumet (CLMT) stock rose 3% after the EPA granted full exemptions for two refineries, removing 71 million RINs from its balance sheet. The company values remaining RINs at $309 million. Calumet is also seeking exemptions for 2022-2024, which are under review. The exemptions improve its financials by reducing compliance costs.

$CLMTMed

S&P upgrades Calumet rating to B- on stronger earnings

S&P Global Ratings upgraded Calumet Inc. to 'B-' from 'CCC+' due to stronger earnings in H1 2026 and improved credit metrics. The company's earnings grew on high margins for specialty oils and renewable fuels. S&P expects adjusted debt to EBITDA of 6x-7x in the next 12 months. Calumet redeemed $100M in senior unsecured notes in July 2026 and plans to expand sustainable aviation fuel production.